For: | Zhang C, Zhang CD, Ma MH, Dai DQ. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. World J Gastroenterol 2018; 24(11): 1206-1215 [PMID: 29568201 DOI: 10.3748/wjg.v24.i11.1206] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i11/1206.htm |
Number | Citing Articles |
1 |
Cheng Zhang, Ying Zou, Dong-Qiu Dai. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1. Biomedicine & Pharmacotherapy 2019; 119: 109417 doi: 10.1016/j.biopha.2019.109417
|
2 |
Lichao Yang, Chunmeng Wei, Yasi Li, Xiao He, Min He. Mir-224 Is An Early-Stage Biomarker of Hepatocellular Carcinoma with Mir-224 and Mir-125B As Prognostic Biomarkers. Biomarkers in Medicine 2020; 14(15): 1485 doi: 10.2217/bmm-2020-0099
|
3 |
Gang Chen, Zhihua Teng, Zhouyu Zhu, Xing Li, Consuelo Amantini. miR-145-3p Hampers the Malignant Progression of Esophageal Carcinoma via CXCL5 Downregulation. Analytical Cellular Pathology 2022; 2022: 1 doi: 10.1155/2022/5418356
|
4 |
Yu-Li Lo, Tse-Yuan Wang, Chun-Jung Chen, Yih-Hsin Chang, Anya Lin. Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer. Pharmaceutics 2022; 14(9): 1759 doi: 10.3390/pharmaceutics14091759
|
5 |
Qiang Dong, Guoqiang Yuan, Min Liu, Qiqi Xie, Jianhong Hu, Maolin Wang, Shangyu Liu, Xiaojun Ma, Yawen Pan. Downregulation of microRNA‑374a predicts poor prognosis in human glioma. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7190
|
6 |
Xuan Chen, Xinji Li, Xiqi Peng, Chunduo Zhang, Kaihao Liu, Guocheng Huang, Yongqing Lai, Andrea Cabrera-Pastor. Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8880937
|
7 |
Yan Qian, Wei Song, Xu Wu, Guowei Hou, Haixiao Wang, Xiao Hang, Tianfang Xia. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290. Digestive Diseases and Sciences 2021; 66(2): 460 doi: 10.1007/s10620-020-06223-4
|
8 |
Akihiko Yoshimura, Kenjiro Sawada, Koji Nakamura, Yasuto Kinose, Erika Nakatsuka, Masaki Kobayashi, Mayuko Miyamoto, Kyoso Ishida, Yuri Matsumoto, Michiko Kodama, Kae Hashimoto, Seiji Mabuchi, Tadashi Kimura. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4974-5
|
9 |
Srinivasulu Yerukala Sathipati, Ming-Ju Tsai, Tonia Carter, Patrick Allaire, Sanjay K. Shukla, Afshin Beheshti, Shinn-Ying Ho. Survival estimation in patients with stomach and esophageal carcinoma using miRNA expression profiles. Computational and Structural Biotechnology Journal 2022; 20: 4490 doi: 10.1016/j.csbj.2022.08.025
|
10 |
Hyun-Ji Lee, Sun Min Lee. Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(3): 168 doi: 10.7704/kjhugr.2018.18.3.168
|
11 |
Wenqian Qi, Qian Zhang. Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer. PeerJ 2021; 9: e10462 doi: 10.7717/peerj.10462
|
12 |
Qingping Song, Hui Liu, Chengyan Li, Haifeng Liang. miR-33a-5p inhibits the progression of esophageal cancer through the DKK1-mediated Wnt/β-catenin pathway. Aging 2021; 13(16): 20481 doi: 10.18632/aging.203430
|
13 |
Lin Liang, Yuwei Zheng, Yanli Wang. <p>miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1</p>. Cancer Management and Research 2020; : 5301 doi: 10.2147/CMAR.S244167
|
14 |
Xiao-Rong Ye, De-Biao Pan, Li-Fu Wang. Expression of miR-145-3p in hepatocellular cancer and its regulatory effect on growth of hepatocellular cancer cells. World Chinese Journal of Digestology 2020; 28(17): 827 doi: 10.11569/wcjd.v28.i17.827
|
15 |
Ruijie Wu, Bohan Zhang, Mengju He, Yani Kang, Gong Zhang. MicroRNA biomarkers and their use in evaluating the prognosis of lung cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(18): 16753 doi: 10.1007/s00432-023-05404-8
|
16 |
Tasuku Matsuoka, Masakazu Yashiro. Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer. International Journal of Molecular Sciences 2024; 25(11): 5880 doi: 10.3390/ijms25115880
|
17 |
Yulai Tang, Aamir Fahira, Siying Lin, Yiming Shao, Zunnan Huang. Shared and specific competing endogenous RNAs network mining in four digestive system tumors. Computational and Structural Biotechnology Journal 2024; 23: 4271 doi: 10.1016/j.csbj.2024.11.005
|
18 |
Guangming Liu, Qiufeng Wan, Jingwen Li, Xinying Hu, Xingli Gu, Sicheng Xu. Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2 (DRAM2). Cell Cycle 2020; 19(22): 3182 doi: 10.1080/15384101.2020.1838792
|
19 |
Guodong Yang, Yujiao Zhang, Jiyuan Yang. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01207
|
20 |
Guangli Sun, Zheng Li, Zhongyuan He, Weizhi Wang, Sen Wang, Xing Zhang, Jiacheng Cao, Penghui Xu, Haixiao Wang, Xiaoxu Huang, Yiwen Xia, Jialun Lv, Zhe Xuan, Tianlu Jiang, Lang Fang, Jing Yang, Diancai Zhang, Hao Xu, Zekuan Xu. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01758-w
|
21 |
Eveline E. Vietsch, Ivana Peran, Mustafa Suker, Thierry P. P. van den Bosch, Fleur van der Sijde, Johan M. Kros, Casper H. J. van Eijck, Anton Wellstein. Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection. Applied Sciences 2019; 9(22): 4784 doi: 10.3390/app9224784
|
22 |
Zhenhai Wu, Pengyuan Liu, Ganlu Zhang. Identification of circRNA–miRNA–Immune-Related mRNA Regulatory Network in Gastric Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.816884
|
23 |
Guan Li, Sheng Ao, Jianing Hou, Guoqing Lyu. Low expression of miR‑125a‑5p is associated with poor prognosis in patients with gastric cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10423
|
24 |
Zhanpeng Luo, Yi Yang, Dawei Li, Long Yu, Ning Liu, Litao Li, Yuanzheng Ma. Circular RNA 0086996 regulates growth and migration of osteosarcoma cells via miR-125b-5p. Pathology - Research and Practice 2020; 216(11): 153230 doi: 10.1016/j.prp.2020.153230
|
25 |
Maria F. Iannó, Veronica Biassoni, Elisabetta Schiavello, Andrea Carenzo, Luna Boschetti, Lorenza Gandola, Barbara Diletto, Edoardo Marchesi, Claudia Vegetti, Alessandra Molla, Christof M. Kramm, Dannis G. van Vuurden, Patrizia Gasparini, Francesca Gianno, Felice Giangaspero, Piergiorgio Modena, Brigitte Bison, Andrea Anichini, Sabina Vennarini, Emanuele Pignoli, Maura Massimino, Loris De Cecco. A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy. Cancers 2022; 14(17): 4307 doi: 10.3390/cancers14174307
|
26 |
Jingxuan Xu, Jian Wen, Shuangquan Li, Xian Shen, Tao You, Yingpeng Huang, Chongyong Xu, Yaping Zhao. Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.690598
|
27 |
Wenjia Liu, Nanjiao Ying, Xin Rao, Xiaodong Chen. MiR-942-3p as a Potential Prognostic Marker of Gastric Cancer Associated with AR and MAPK/ERK Signaling Pathway. Current Issues in Molecular Biology 2022; 44(9): 3835 doi: 10.3390/cimb44090263
|